Part Details | USP LACTULOSE SOLUTION
6505-01-132-4610
Alternate Parts: NDC00068041364, NDC00068-0413-64, CEPHULAC, 41364, NDC00472135832, NDC00472-1358-32, 6505-01-132-4610, 01-132-4610, 6505011324610, 011324610
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | MAY 30, 1982 | 01-132-4610 | 47950 ( LACTULOSE SOLUTION, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-132-4610
Part Number | Cage Code | Manufacturer |
---|---|---|
NDC00068-0413-64 | 51889 | MERRELL DOW PHARMECEUTICALS INCBIDS AND CONTRACTS DEPT |
CEPHULAC | 51889 | MERRELL DOW PHARMECEUTICALS INCBIDS AND CONTRACTS DEPT |
41364 | 51889 | MERRELL DOW PHARMECEUTICALS INCBIDS AND CONTRACTS DEPT |
NDC00472-1358-32 | 57979 | NATIONAL PHARMACEUTICAL MFG COA DIV OF BARRE-NATIONAL INC |
Technical Data | NSN 6505-01-132-4610
Characteristic | Specifications |
---|---|
PRIMARY CONTAINER TYPE | BOTTLE |
PRIMARY CONTAINER CONTENT QUANTITY | L0.500$JLT1.890 |
ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY0.667 GRAMS LACTULOSE |
ADMINISTRATION | H$M ORAL, NONCHEWABLE |
FLAVOR | |
SPECIAL FEATURES | FOR THE INDICATION OF PORTAL-SYSTEMIC ENCEPHALOPATHY |
PART NAME ASSIGNED BY CONTROLLING AGENCY | LACTULOSE SOLUTION USP 0.5GL OR 1.89LI BT |